The intestinal permeability of neolignans from the seeds of myristica fragrans in the caco-2 cell monolayer model

Planta Medica

Volumn 76, Issue 14, 2010, Pages 1587-1591

  Yang, Xiu Wei ^a   Huang, Xin ^a   Ma, Lian ^a   Wu, Qi ^a   Xu, Wei ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Caco 2 cell monolayer; intestinal permeability; Myristica fragrans; Myristicaceae; neolignans

Indexed keywords

2,3 DIHYDRO 7 METHOXY 3 METHYL 2 [3,4 (METHYLENEDIOXY 5 METHOXYPHENYL] 5 PROPENYLBENZOFURAN; 5 METHOXYDEHYDRODIISOEUGENOL; ATENOLOL; BENZOFURAN DERIVATIVE; DEHYDRODIISOEUGENOL; ERYTHRO 2 (4 ALLYL 2,6 DIMETHOXYPHENOXY) 1 (3,4 DIMETHOXYPHENYL)PROPAN 1 OL; ERYTHRO 2 (4 ALLYL 2,6 DIMETHOXYPHENOXY) 1 (3,4 DIMETHOXYPHENYL)PROPAN 1 OL ACETATE; ERYTHRO 2 (4 ALLYL 2,6 DIMETHOXYPHENOXY) 1 (3,4,5 TRIMETHOXYPHENYL)PROPAN 1 OL; ERYTHRO 2 (4 ALLYL 2,6 DIMETHOXYPHENOXY) 1 (3,4,5 TRIMETHOXYPHENYL)PROPANE; LICARIN B; MYRISLIGNAN; MYRISTICA FRAGRANS EXTRACT; NEOLIGNAN; PLANT EXTRACT; PROPRANOLOL; THREO 2 (4 ALLYL 2,6 DIMETHOXYPHENOXY) 1 (3 HYDROXY 5 METHOXYPHENYL)PROPAN 1 OL; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN CACO 2; DRUG ABSORPTION; DRUG PENETRATION; HUMAN; HUMAN CELL; INTESTINE MUCOSA PERMEABILITY; MYRISTICACEAE; NUTMEG; PLANT SEED;

ATENOLOL; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIFFUSION; HUMANS; INTESTINAL ABSORPTION; INTESTINES; LIGNANS; MYRISTICA FRAGRANS; PERMEABILITY; PROPRANOLOL; SEEDS;

MYRISTICA FRAGRANS; MYRISTICACEAE;

EID: 77957590299     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1249810     Document Type: Article

References (38)

1. Hall R L. Toxicants occurring naturally in spices and flavours. Food Protection Committee, National Research Council Toxicants occurring naturally in foods, 2nd edition. Washington DC National Academy of Sciences 1973 448-463
2. Jin D Q., Lim C S., Hwang J K., Ha I, Han J S. Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cells. Biochem Biophys Res Commun 2005 331 1264-1269
3. Yang S, Kyun N M., Jang J P., Kim K A., Kim B Y., Sung N J., Oh W K., Ahn J S. Inhibition of protein tyrosine phosphatase 1B by lignans from Myristica fragrans. Phytother Res 2006 20 680-682
4. Morita T, Jinno K, Kawagishi H, Arimoto Y, Suganuma H, Inakuma T, Sugiyama K. Hepatoprotective effect of myristicin from nutmeg (Myristica fragrans) on lipopolysaccharide/-galactosamine-induced liver injury. J Agric Food Chem 2003 51 1560-1565
5. Mukherjee P K., Kumar V, Houghton P J. Screening of Indian medicinal plants for acetylcholinesterase inhibitory activity. Phytother Res 2007 21 1142-1145
6. Hussain S P., Rao A R. Chemopreventive action of mace (Myristica fragrans Houtt.) onmethylcholanthrene-induced carcinogenesis in the uterine cervix in mice. Cancer Lett 1991 56 231-234
7. Hattori M, Yang X W., Miyashiro H, Namba T. Inhibitory effects of monomeric and dimeric phenylpropanoids from mace on lipid peroxidation in vivo and in vitro. Phytother Res 1993 7 395-401
8. Ozaki Y, Soedigdo S, Wattimena Y R., Suganda A G. Anti-inflammatory effects of mace, aril of Myristica fragrans Houtt., and its active principles. Jpn J Pharmacol 1989 49 155-163
9. Checker R, Chatterjee S, Sharma D, Gupta S, Variyar P, Sharma A, Poduval T B. Immunomodulatory and radioprotective effects of lignans derived from fresh nutmeg mace (Myristica fragrans) in mammalian splenocytes. Int Immunopharmacol 2008 8 661-669
10. Wang Y, Yang X W. Quantitative determination of neolignanoids in the seeds of Myristica fragrans. Modern Chin Med 2008 10 10-13
11. Yang X W., Huang X, Ahmat M. New neolignan from seed of Myristica fragrans. China J Chin Mater Med 2008 33 397-402
12. Hada S, Hattori M, Tezuka Y, Kikuchi T, Namba T. New neolignans and lignans from the aril of Myristica fragrans. Phytochemistry 1988 27 563-568
13. Hattori M, Hada S, Kawata Y, Tezuka Y, Kikuchi T, Namba T. New 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignans from the aril of Myristica fragrans. Chem Pharm Bull 1987 35 3315-3322
14. Hattori M, Hada S, Shu Y Z., Kikuchi T, Namba T. New acyclic bis-phenylpropanoids from the aril of Myristica fragrans. Chem Pharm Bull 1987 35 668-674
15. Hattori M, Yang X W., Shu Y Z., Kakiuchi N, Tezuka Y, Kikuchi T, Namba T. New constituents of the aril of Myristica fragrans Houtt. Chem Pharm Bull 1988 36 648-654
16. Isogai A, Murakoshi S, Suzuki A, Tamura S. Isolation from nutmeg of growth inhibitory substances to Silkworm larvae. Agric Biol Chem 1973 37 889-895
17. Isogai A, Suzuki A, Tamura S. Structures of dimeric from Myristica fragrans Houtt. Agric Biol Chem 1973 37 193-194
18. Li F, Yang X W. Three new neolignans from the Aril of Myristica fragrans. Helv Chim Acta 2007 90 1491-1496
19. Murakami Y, Shoji M, Hirata A, Tanaka S, Yokoe I, Fujisawa S. Dehydrodiisoeugenol, an isoeugenol dimer, inhibits lipopolysaccharide-stimulated nuclear factor kappa B activation and cyclooxygenase-2 expression in macrophages. Arch Biochem Biophys 2005 434 326-332
20. Tsai I L., Hsieh C F., Duh C Y., Chen I S. Further study on the chemical constituents and their cytotoxicity from the leaves of Persea obovatifolia. Chin Pharm J 1999 51 335-345
21. Lee S U., Shim K S., Ryu S Y., Min Y K., Kim S H. Machilin A isolated from Myristica fragrans stimulates osteoblast differentiation. Planta Med 2009 75 152-157
22. Li F, Yang X W. Quantification of myrislignan in rat plasma by solid-phase extraction and reversed-phase high-performance liquid chromatography. Biomed Chromatogr 2008 22 601-605
23. Li F, Yang X W. Determination of dehydrodiisoeugenol in rat tissues using HPLC method. Biomed Chromatogr 2008 22 1202-1212
24. Li F, Yang X W. Simultaneous determination of diastereomers (+)-licarin A and isolicarin A from Myristica fragrans in rat plasma by HPLC and its application to their pharmacokinetics. Planta Med 2008 74 880-884
25. Kasahara H, Miyazawa M, Kameoka H. Biotransformation of an acyclic neolignan in rats. Phytochemistry 1995 38 343-346
26. Li F, Yang X W. Biotransformation of myrislignan by rat liver microsomes in vitro. Phytochemistry 2008 69 765-771
27. Yang X W., Yang X D., Wang Y, Ma L, Zhang Y, Yang X G., Wang K. Establishment of Caco-2 cell monolayer model and the standard operation procedure for assessing intestinal absorption of chemical components of traditional Chinese medicine. J Chin Integr Med 2007 5 634-641
28. Lennernas H, Palm K, Fagerholm U, Artursson P. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int J Pharm 1996 127 103-107
29. Artursson P A., Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 1991 175 880-885
30. Chong S, Dando S A., Morrison R A. Evaluation of biocoat intestinal epithelium differentiation environment (3-day cultured Caco-2 cells) as an absorption screening model with improved productivity. Pharm Res 1997 14 1835-1837
31. Takahashi Y, Kondo H, Yasuda T, Watanabe T, Kobayashi S I., Yokohama S. Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs. Int J Pharm 2002 246 85-94
32. Yee S Y. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man fact or myth. Pharm Res 1997 14 763-766
33. Sharom F J. The P-glycoprotein efflux pump: how does it transport drugs J Membr Biol 1997 160 161-175
34. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1981 41 1967-1972
35. Jedlitschky G, Leier I, Buchholz U. ATP-dependent transport of glutathine S -conjugates by the multidrug resistance-associated protein. Cancer Res 1994 54 4833-4836
36. 4 and structurally related conjugates. J Biol Chem 1994 269 27807-27810
37. Madgula V L. M., Avula B, Choi Y W., Pullela S V., Khan I A., Walker L A., Khan S I. Transport of Schisandra chinensis extract and its biologically active constituents across Caco-2 cell monolayers an in vitro model of intestinal transport. J Pharm Pharmacol 2008 60 363-370
38. Wils P, Warnery A, Phung-Ba V, Legrain S, Scherman D. High lipophilicity decreases drug transport across intestinal epithelial cells. J Pharm Exp Ther 1994 269 654-658